Study for Assessing the Prevalence of Airflow Limitation in Outpatients with History of Smoking Attending Cardiology Clinics

Trial Identifier:	D5980R00124
Sponsor:	AstraZeneca
Start Date:	December 2025
Primary Completion Date:	September 2026
Study Completion Date:	September 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Turkey	Ankara, Turkey
Turkey	Istanbul, Turkey

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.